
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
After Pfizer’s aborted acquisition of AstraZeneca, will the drug maker likely approach another company for takeover?
After Pfizer’s aborted acquisition of AstraZeneca, will the drug maker likely approach another company for takeover? This






